Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT-Reference-Cited by-同舟云学术

Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT

Published:2014-06-25 Issue:242 Volume:6 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Papadopoulou Anastasia¹,Gerdemann Ulrike¹,Katari Usha L.¹,Tzannou Ifigenia¹,Liu Hao¹,Martinez Caridad¹,Leung Kathryn¹,Carrum George¹,Gee Adrian P.¹,Vera Juan F.¹,Krance Robert A.¹,Brenner Malcolm K.¹,Rooney Cliona M.¹,Heslop Helen E.¹,Leen Ann M.¹

Affiliation:

1. Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, Houston Methodist Hospital, Houston, TX 77030, USA.

Abstract

Rapidly generated broad-spectrum T cells can simultaneously treat multiple viral infections after hematopoietic stem cell transplant.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference59 articles.

1. Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

2. Hematopoietic Stem Cell Transplantation: An Overview of Infection Risks and Epidemiology

3. Donor T Cells to Treat EBV-Associated Lymphoma